loading

Cardiff Oncology Inc Stock (CRDF) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
31.41%
0.205
0.156 0.141 0.108 0.083
Operating Expenses
6.20%
11.14
10.49 10.96 12.32 12.13
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
6.20%
11.14
10.49 10.96 12.32 12.13
Operating Income/Loss
5.82%
-10.93
-10.33 -10.82 -12.21 -12.05
Nonoperating Income/Loss
7.34%
0.922
0.995 1.089 1.058 0.829
Income/Loss From Continuing Operations Before Tax
31.41%
0.205
0.156 0.141 -11.15 -11.22
Income/Loss From Continuing Operations After Tax
7.22%
-10.01
-9.337 -9.731 -11.15 -11.22
Net Income/Loss
7.22%
-10.01
-9.337 -9.731 -11.15 -11.22
Preferred Stock Dividends And Other Adjustments
0.00%
0.006
0.006 0.006 - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
44.68
- 44.68 44.68 44.68
Diluted Average Shares
44.68
- 44.68 44.68 44.68
Basic Earnings Per Share
4.76%
-0.22
-0.21 -0.22 -0.25 -0.25
Diluted Earnings Per Share
4.76%
-0.22
-0.21 -0.22 -0.25 -0.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
0.00%
0.006
0.006 0.006 - -
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):